Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Eon's Cyclosporine Capsules Receive Approval As First-Time Neoral Generic

Executive Summary

FDA's generic drugs office opened 2000 with the Jan. 13 approval of Eon Labs' cyclosporine softgel capsules as the first generic of Novartis' Neoral capsules, which comprise 96% of the cyclosporine market.

You may also be interested in...



Eon Generic Transdermal Estrogen Patch Under Development With Hexal AG

Eon Labs is developing a generic transdermal estrogen patch with German partner Hexal AG

Eon Generic Transdermal Estrogen Patch Under Development With Hexal AG

Eon Labs is developing a generic transdermal estrogen patch with German partner Hexal AG

Mylan Wins Argument In Exclusivity Case, But Not Terazosin Approval

Mylan will have to wait until after Feb. 9 to launch its generic terazosin capsules even though the company has won a federal court ruling that Geneva's 180-day exclusivity for the product should have already expired.

Related Content

UsernamePublicRestriction

Register

PS035435

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel